Proteus Genomics

Proteus Genomics is a highly-specialized, ground-breaking, genetic, infectious disease, microbiology laboratory. We are the undisputed leader in providing targeted, molecular diagnostics (PCR), focused on developing solutions to improve clinical and economic outcomes. Our distinct area of expertise is real-time quantitative reverse transcription polymerase chain reaction (RT qRT-PCR) and next generation DNA sequencing (NGS). Our high-complexity CLIA clinical reference scientists have developed an unparalleled suite of custom arrays. Proteus Genomics proprietary test panels include UTI, Wound, Nail, Respiratory, COVID, STI, and Womens Health. These novel, proprietary test offerings provide our partner physicians and providers the broadest, clearest, actionable patient results, as...

Microbiology,molecular testing,molecular biology,pcr,polymerase chain reaction,rt qrt-pcr,next generation dna sequencing (ngs),qpcr,antibiotic resistance,pathogen,antibiotic stewardship,infectious disease,long term care,primary care,urology,wound care,nursing homes,assisted living,internal medicine,vascular,cardiology,obgyn,quick care,walk in care,specialty clinic,women's health,sti,pharmacogenomics,pgx,laboratory,genetic testing,genomics,lab,molecular diagnostics,proprietary,clinical outcomes,economic outcomes,physicain,provider,clinician,science,health systems,hospital,hospital care,covid-19,sars-cov-2,corona virus,antibody,test,doctor,laboratory sales,clinical outcomes,nursing home,and covid

Proteus genomics operates in the Biotechnology research industry.

Proteus genomics's revenue is 11m - 100m

Proteus genomics has 11 - 50 employees.